Olopatadine Hydrochloride Ophthalmic Solution USP, 0.2% (OTC), will be distributed in the US by Glenmark Therapeutics, USA.
Empagliflozin and its Fixed Drug Combinations (FDCs) have been launched under the brand names Glempa, Glempa –L and Glempa-M
403 entries from 22 states covering 168 districts highlight groundbreaking initiatives vital to improving national nutrition metrics.
Glenmark’s consolidated revenue was at Rs. 3,387.6 crore as against Rs. 2,506.7 crore recording an increase of 35.1% YoY
According to IQVIATM sales data for the 12-month period ending October 2024, the Vimpat Oral Solution, 10 mg/mL market achieved annual sales of approximately $57.0 million
This addition highlights our commitment to meeting market needs and providing high-quality over the-counter solutions for our customers
India Business grew by 11.9% YoY to Rs. 1196.2 crore
_256_384.jpg)
Glenmark released Picture Post Cards on World Vitiligo Day
Subscribe To Our Newsletter & Stay Updated
